Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TGT vs GSK✓SelectedUSD · GSKTGT vs GSK performance historyLatest closeAs of-0.70%11/16
Stock and ETF performance explorer

TGT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+184.3%
GSK return
+107.3%
Excess return
+77.0%
Maximum drawdown
-64.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.6%-0.7%
7D-2.7%-1.3%-1.4%-2.3%
30D+4.7%+2.7%+1.9%+3.9%
3M+4.5%+2.7%+1.8%+3.6%
6M+33.9%+3.3%+30.5%+32.3%
YTD+69.7%+6.5%+63.3%+65.4%
1Y+84.5%+10.7%+73.9%+77.9%
3Y+37.3%+64.4%-27.1%+14.4%
5Y-29.4%+46.7%-76.1%-39.6%
10Y+184.3%+109.4%+74.9%+106.6%
All+184.3%+107.3%+77.0%+106.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling